Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.56 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.53 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.53 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119973 | 0.97 | PRKCA (0.61) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL23231501 | 0.92 | ALDH1A1 (0.69) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL13901084 | 0.85 | PRKCA (0.85) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL9716947 | 0.85 | PRKCA (0.85) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL3918449 | 0.85 | PRKCA (0.85) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL17788987 | 0.85 | LMNA (0.57) | PRKCAALDH1A1LMNALPAR3LPAR1 | |
| SCHEMBL3334747 | 0.83 | PRKCA (0.51) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL207207 | 0.83 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL385481 | 0.83 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL385978 | 0.83 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058232-A1 | Method for the preparation of diacetyl tartaric acid esters of mono-and di-glycerides | LIU GAOFENG (CN) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058232-A1 | Method for the preparation of diacetyl tartaric acid esters of mono-and di-glycerides | DGAT2, DGAT1, DGKA | PRKCA 45/4885ALDH1A1 1964/4885LMNA 2777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.